Top Markets
Coin of the day
Grace Therapeutics, Inc. Grace Therapeutics, Inc.

Grace Therapeutics, Inc.

GRCE
Kedudukan dalam Saham #27034
Grace Therapeutics, Inc. specializes in the creation and commercialization of... Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betamethasone spray intended for the management of ataxia-telangiectasia, and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. Established in 2002, the enterprise previously operated under the name Acasti Pharma Inc., before officially adopting Grace Therapeutics, Inc. in October 2024. The company's main offices are located in Princeton, New Jersey.
Harga Saham
$2.18
Disegerakkan terakhir: 2026-08-19
Modal Pasaran
$35.55M
Perubahan (1 hari)
2.57%
Perubahan (1 tahun)
-33.19%
Negara
US
Perdagangan Grace Therapeutics, Inc. (GRCE)

Kategori

Sejarah pecahan saham untuk Grace Therapeutics, Inc. (GRCE)
Saham Grace Therapeutics, Inc. (simbol: GRCE) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 20, 2026.
Satu saham GRCE yang dibeli sebelum Aug 20, 2026 kini bersamaan dengan 0 saham GRCE.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH